Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 2003 Oct 15;375(Pt 2):351–363. doi: 10.1042/BJ20030636

Molecular characterization of the constitutive expression of the plasma platelet-activating factor acetylhydrolase gene in macrophages.

Xiaoqing Wu 1, Thomas M McIntyre 1, Guy A Zimmerman 1, Stephen M Prescott 1, Diana M Stafforini 1
PMCID: PMC1223687  PMID: 12854969

Abstract

Plasma platelet-activating factor acetylhydrolase (PAF-AH) is a phospholipase that inactivates platelet-activating factor (PAF) and PAF-like lipids to generate products with little or no biological activity. The levels of circulating PAF-AH correlate with several disease syndromes. We previously reported that mediators of inflammation regulate the expression of the human PAF-AH gene at the transcriptional level. In the present paper, we characterize the constitutive expression of plasma PAF-AH using the mouse gene as a model system, and we report comparative results obtained using human and mouse promoter constructs. We first cloned, sequenced and analysed the promoter region of the murine plasma PAF-AH (mPAF-AH) gene and found that this gene lacks a canonical TATA box. We demonstrated that the cis -elements required for basal transcription are localized within the -316 to -68 bp region. In vitro band-shift and supershift assays showed that Sp1 and Sp3 transcription factors from RAW264.7 and J774A.1 macrophage nuclear extracts bound strongly to a distal GC-rich site within -278/-243 [specificity protein (Sp-A)] and to a proximal TC-rich motif within -150/-114 (Sp-B). In addition, we observed weak binding to a GA-rich site within -110/-82 (Sp-C). The regions containing Sp-B and Sp-C are highly conserved between the human and mouse genes. Forced expression of Sp1 or Sp3 in Sp-lacking Drosophila SL2 cells induced markedly the activity of the exogenous mPAF-AH promoter in a dose-dependent manner, and this induction was dependent on the presence of intact Sp-A and Sp-B. Interestingly, we found that the Sp1- and Sp3-associated DNA-binding activities increased during the maturation of primary human monocytes into macrophages in cell culture. These results demonstrate that Sp1 and Sp3 are key factors that contribute to the basal, constitutive transcription of the plasma PAF-AH gene in macrophages.

Full Text

The Full Text of this article is available as a PDF (386.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Asano K., Okamoto S., Fukunaga K., Shiomi T., Mori T., Iwata M., Ikeda Y., Yamaguchi K. Cellular source(s) of platelet-activating-factor acetylhydrolase activity in plasma. Biochem Biophys Res Commun. 1999 Aug 2;261(2):511–514. doi: 10.1006/bbrc.1999.1066. [DOI] [PubMed] [Google Scholar]
  2. Böhm S. K., Gum J. R., Jr, Erickson R. H., Hicks J. W., Kim Y. S. Human dipeptidyl peptidase IV gene promoter: tissue-specific regulation from a TATA-less GC-rich sequence characteristic of a housekeeping gene promoter. Biochem J. 1995 Nov 1;311(Pt 3):835–843. doi: 10.1042/bj3110835. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cao Y., Stafforini D. M., Zimmerman G. A., McIntyre T. M., Prescott S. M. Expression of plasma platelet-activating factor acetylhydrolase is transcriptionally regulated by mediators of inflammation. J Biol Chem. 1998 Feb 13;273(7):4012–4020. doi: 10.1074/jbc.273.7.4012. [DOI] [PubMed] [Google Scholar]
  4. Chen H. M., Pahl H. L., Scheibe R. J., Zhang D. E., Tenen D. G. The Sp1 transcription factor binds the CD11b promoter specifically in myeloid cells in vivo and is essential for myeloid-specific promoter activity. J Biol Chem. 1993 Apr 15;268(11):8230–8239. [PubMed] [Google Scholar]
  5. Dennig J., Beato M., Suske G. An inhibitor domain in Sp3 regulates its glutamine-rich activation domains. EMBO J. 1996 Oct 15;15(20):5659–5667. [PMC free article] [PubMed] [Google Scholar]
  6. Dennis E. A. The growing phospholipase A2 superfamily of signal transduction enzymes. Trends Biochem Sci. 1997 Jan;22(1):1–2. doi: 10.1016/s0968-0004(96)20031-3. [DOI] [PubMed] [Google Scholar]
  7. Dignam J. D., Lebovitz R. M., Roeder R. G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 1983 Mar 11;11(5):1475–1489. doi: 10.1093/nar/11.5.1475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Elstad M. R., Stafforini D. M., McIntyre T. M., Prescott S. M., Zimmerman G. A. Platelet-activating factor acetylhydrolase increases during macrophage differentiation. A novel mechanism that regulates accumulation of platelet-activating factor. J Biol Chem. 1989 May 25;264(15):8467–8470. [PubMed] [Google Scholar]
  9. Emili A., Greenblatt J., Ingles C. J. Species-specific interaction of the glutamine-rich activation domains of Sp1 with the TATA box-binding protein. Mol Cell Biol. 1994 Mar;14(3):1582–1593. doi: 10.1128/mcb.14.3.1582. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Fandos C., Sánchez-Feutrie M., Santalucía T., Viñals F., Cadefau J., Gumà A., Cussó R., Kaliman P., Canicio J., Palacín M. GLUT1 glucose transporter gene transcription is repressed by Sp3. Evidence for a regulatory role of Sp3 during myogenesis. J Mol Biol. 1999 Nov 19;294(1):103–119. doi: 10.1006/jmbi.1999.3216. [DOI] [PubMed] [Google Scholar]
  11. Ghayor C., Chadjichristos C., Herrouin J. F., Ala-Kokko L., Suske G., Pujol J. P., Galera P. Sp3 represses the Sp1-mediated transactivation of the human COL2A1 gene in primary and de-differentiated chondrocytes. J Biol Chem. 2001 Jul 10;276(40):36881–36895. doi: 10.1074/jbc.M105083200. [DOI] [PubMed] [Google Scholar]
  12. Hagen G., Müller S., Beato M., Suske G. Sp1-mediated transcriptional activation is repressed by Sp3. EMBO J. 1994 Aug 15;13(16):3843–3851. doi: 10.1002/j.1460-2075.1994.tb06695.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hata Y., Duh E., Zhang K., Robinson G. S., Aiello L. P. Transcription factors Sp1 and Sp3 alter vascular endothelial growth factor receptor expression through a novel recognition sequence. J Biol Chem. 1998 Jul 24;273(30):19294–19303. doi: 10.1074/jbc.273.30.19294. [DOI] [PubMed] [Google Scholar]
  14. Hauses M., Tönjes R. R., Grez M. The transcription factor Sp1 regulates the myeloid-specific expression of the human hematopoietic cell kinase (HCK) gene through binding to two adjacent GC boxes within the HCK promoter-proximal region. J Biol Chem. 1998 Nov 27;273(48):31844–31852. doi: 10.1074/jbc.273.48.31844. [DOI] [PubMed] [Google Scholar]
  15. Henderson W. R., Jr, Lu J., Poole K. M., Dietsch G. N., Chi E. Y. Recombinant human platelet-activating factor-acetylhydrolase inhibits airway inflammation and hyperreactivity in mouse asthma model. J Immunol. 2000 Mar 15;164(6):3360–3367. doi: 10.4049/jimmunol.164.6.3360. [DOI] [PubMed] [Google Scholar]
  16. Hoppe K. L., Francone O. L. Binding and functional effects of transcription factors Sp1 and Sp3 on the proximal human lecithin:cholesterol acyltransferase promoter. J Lipid Res. 1998 May;39(5):969–977. [PubMed] [Google Scholar]
  17. Howard K. M., Miller J. E., Miwa M., Olson M. S. Cell-specific regulation of expression of plasma-type platelet-activating factor acetylhydrolase in the liver. J Biol Chem. 1997 Oct 31;272(44):27543–27548. doi: 10.1074/jbc.272.44.27543. [DOI] [PubMed] [Google Scholar]
  18. Kumar A. P., Butler A. P. Transcription factor Sp3 antagonizes activation of the ornithine decarboxylase promoter by Sp1. Nucleic Acids Res. 1997 May 15;25(10):2012–2019. doi: 10.1093/nar/25.10.2012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Liang Liang, Major Terry, Bocan Thomas. Characterization of the promoter of human extracellular matrix metalloproteinase inducer (EMMPRIN). Gene. 2002 Jan 9;282(1-2):75–86. doi: 10.1016/s0378-1119(01)00847-2. [DOI] [PubMed] [Google Scholar]
  20. Lu J., Lee W., Jiang C., Keller E. B. Start site selection by Sp1 in the TATA-less human Ha-ras promoter. J Biol Chem. 1994 Feb 18;269(7):5391–5402. [PubMed] [Google Scholar]
  21. Majello B., De Luca P., Lania L. Sp3 is a bifunctional transcription regulator with modular independent activation and repression domains. J Biol Chem. 1997 Feb 14;272(7):4021–4026. doi: 10.1074/jbc.272.7.4021. [DOI] [PubMed] [Google Scholar]
  22. Narahara H., Frenkel R. A., Johnston J. M. Secretion of platelet-activating factor acetylhydrolase following phorbol ester-stimulated differentiation of HL-60 cells. Arch Biochem Biophys. 1993 Mar;301(2):275–281. doi: 10.1006/abbi.1993.1144. [DOI] [PubMed] [Google Scholar]
  23. Nothias J. Y., Majumder S., Kaneko K. J., DePamphilis M. L. Regulation of gene expression at the beginning of mammalian development. J Biol Chem. 1995 Sep 22;270(38):22077–22080. doi: 10.1074/jbc.270.38.22077. [DOI] [PubMed] [Google Scholar]
  24. Noti J. D., Reinemann B. C., Petrus M. N. Sp1 binds two sites in the CD11c promoter in vivo specifically in myeloid cells and cooperates with AP1 to activate transcription. Mol Cell Biol. 1996 Jun;16(6):2940–2950. doi: 10.1128/mcb.16.6.2940. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Noti J. D. Sp3 mediates transcriptional activation of the leukocyte integrin genes CD11C and CD11B and cooperates with c-Jun to activate CD11C. J Biol Chem. 1997 Sep 19;272(38):24038–24045. doi: 10.1074/jbc.272.38.24038. [DOI] [PubMed] [Google Scholar]
  26. Packard C. J., O'Reilly D. S., Caslake M. J., McMahon A. D., Ford I., Cooney J., Macphee C. H., Suckling K. E., Krishna M., Wilkinson F. E. Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group. N Engl J Med. 2000 Oct 19;343(16):1148–1155. doi: 10.1056/NEJM200010193431603. [DOI] [PubMed] [Google Scholar]
  27. Prescott S. M., Zimmerman G. A., McIntyre T. M. Platelet-activating factor. J Biol Chem. 1990 Oct 15;265(29):17381–17384. [PubMed] [Google Scholar]
  28. Prescott S. M., Zimmerman G. A., Stafforini D. M., McIntyre T. M. Platelet-activating factor and related lipid mediators. Annu Rev Biochem. 2000;69:419–445. doi: 10.1146/annurev.biochem.69.1.419. [DOI] [PubMed] [Google Scholar]
  29. Quandt K., Frech K., Karas H., Wingender E., Werner T. MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res. 1995 Dec 11;23(23):4878–4884. doi: 10.1093/nar/23.23.4878. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Quarck R., De Geest B., Stengel D., Mertens A., Lox M., Theilmeier G., Michiels C., Raes M., Bult H., Collen D. Adenovirus-mediated gene transfer of human platelet-activating factor-acetylhydrolase prevents injury-induced neointima formation and reduces spontaneous atherosclerosis in apolipoprotein E-deficient mice. Circulation. 2001 May 22;103(20):2495–2500. doi: 10.1161/01.cir.103.20.2495. [DOI] [PubMed] [Google Scholar]
  31. Saffer J. D., Jackson S. P., Annarella M. B. Developmental expression of Sp1 in the mouse. Mol Cell Biol. 1991 Apr;11(4):2189–2199. doi: 10.1128/mcb.11.4.2189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Six D. A., Dennis E. A. The expanding superfamily of phospholipase A(2) enzymes: classification and characterization. Biochim Biophys Acta. 2000 Oct 31;1488(1-2):1–19. doi: 10.1016/s1388-1981(00)00105-0. [DOI] [PubMed] [Google Scholar]
  33. Smale S. T., Schmidt M. C., Berk A. J., Baltimore D. Transcriptional activation by Sp1 as directed through TATA or initiator: specific requirement for mammalian transcription factor IID. Proc Natl Acad Sci U S A. 1990 Jun;87(12):4509–4513. doi: 10.1073/pnas.87.12.4509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Smale S. T. Transcription initiation from TATA-less promoters within eukaryotic protein-coding genes. Biochim Biophys Acta. 1997 Mar 20;1351(1-2):73–88. doi: 10.1016/s0167-4781(96)00206-0. [DOI] [PubMed] [Google Scholar]
  35. Stafforini D. M., Elstad M. R., McIntyre T. M., Zimmerman G. A., Prescott S. M. Human macrophages secret platelet-activating factor acetylhydrolase. J Biol Chem. 1990 Jun 15;265(17):9682–9687. [PubMed] [Google Scholar]
  36. Stafforini D. M., McIntyre T. M., Zimmerman G. A., Prescott S. M. Platelet-activating factor acetylhydrolases. J Biol Chem. 1997 Jul 18;272(29):17895–17898. doi: 10.1074/jbc.272.29.17895. [DOI] [PubMed] [Google Scholar]
  37. Stafforini D. M., Numao T., Tsodikov A., Vaitkus D., Fukuda T., Watanabe N., Fueki N., McIntyre T. M., Zimmerman G. A., Makino S. Deficiency of platelet-activating factor acetylhydrolase is a severity factor for asthma. J Clin Invest. 1999 Apr;103(7):989–997. doi: 10.1172/JCI5574. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Stafforini D. M., Tjoelker L. W., McCormick S. P., Vaitkus D., McIntyre T. M., Gray P. W., Young S. G., Prescott S. M. Molecular basis of the interaction between plasma platelet-activating factor acetylhydrolase and low density lipoprotein. J Biol Chem. 1999 Mar 12;274(11):7018–7024. doi: 10.1074/jbc.274.11.7018. [DOI] [PubMed] [Google Scholar]
  39. Tjoelker L. W., Eberhardt C., Unger J., Trong H. L., Zimmerman G. A., McIntyre T. M., Stafforini D. M., Prescott S. M., Gray P. W. Plasma platelet-activating factor acetylhydrolase is a secreted phospholipase A2 with a catalytic triad. J Biol Chem. 1995 Oct 27;270(43):25481–25487. doi: 10.1074/jbc.270.43.25481. [DOI] [PubMed] [Google Scholar]
  40. Tjoelker L. W., Stafforini D. M. Platelet-activating factor acetylhydrolases in health and disease. Biochim Biophys Acta. 2000 Oct 31;1488(1-2):102–123. doi: 10.1016/s1388-1981(00)00114-1. [DOI] [PubMed] [Google Scholar]
  41. Tjoelker L. W., Wilder C., Eberhardt C., Stafforini D. M., Dietsch G., Schimpf B., Hooper S., Le Trong H., Cousens L. S., Zimmerman G. A. Anti-inflammatory properties of a platelet-activating factor acetylhydrolase. Nature. 1995 Apr 6;374(6522):549–553. doi: 10.1038/374549a0. [DOI] [PubMed] [Google Scholar]
  42. Tone M., Powell M. J., Tone Y., Thompson S. A., Waldmann H. IL-10 gene expression is controlled by the transcription factors Sp1 and Sp3. J Immunol. 2000 Jul 1;165(1):286–291. doi: 10.4049/jimmunol.165.1.286. [DOI] [PubMed] [Google Scholar]
  43. Venable M. E., Zimmerman G. A., McIntyre T. M., Prescott S. M. Platelet-activating factor: a phospholipid autacoid with diverse actions. J Lipid Res. 1993 May;34(5):691–702. [PubMed] [Google Scholar]
  44. Wieczorek E., Lin Z., Perkins E. B., Law D. J., Merchant J. L., Zehner Z. E. The zinc finger repressor, ZBP-89, binds to the silencer element of the human vimentin gene and complexes with the transcriptional activator, Sp1. J Biol Chem. 2000 Apr 28;275(17):12879–12888. doi: 10.1074/jbc.275.17.12879. [DOI] [PubMed] [Google Scholar]
  45. Yamada A., Takaki S., Hayashi F., Georgopoulos K., Perlmutter R. M., Takatsu K. Identification and characterization of a transcriptional regulator for the lck proximal promoter. J Biol Chem. 2001 Mar 13;276(21):18082–18089. doi: 10.1074/jbc.M008387200. [DOI] [PubMed] [Google Scholar]
  46. Zhang D. E., Hetherington C. J., Tan S., Dziennis S. E., Gonzalez D. A., Chen H. M., Tenen D. G. Sp1 is a critical factor for the monocytic specific expression of human CD14. J Biol Chem. 1994 Apr 15;269(15):11425–11434. [PubMed] [Google Scholar]
  47. Zimmerman Guy A., McIntyre Thomas M., Prescott Stephen M., Stafforini Diana M. The platelet-activating factor signaling system and its regulators in syndromes of inflammation and thrombosis. Crit Care Med. 2002 May;30(5 Suppl):S294–S301. doi: 10.1097/00003246-200205001-00020. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES